TMO
Thermo Fisher Scientific Inc.
- Free cash flow, 2025
- $6.3B
- YoY, 2025
- −13.4%
- 5-year CAGR
- −1.6%
- 10-year CAGR
- +9.6%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $6.3B | −13.4% |
| 2024 | $7.3B | +4.9% |
| 2023 | $6.9B | +0.2% |
| 2022 | $6.9B | +1.8% |
| 2021 | $6.8B | −0.4% |
| 2020 | $6.8B | +68.4% |
| 2019 | $4.0B | +6.9% |
| 2018 | $3.8B | +8.2% |
| 2017 | $3.5B | +24.3% |
| 2016 | $2.8B | +11.7% |
| 2015 | $2.5B | +14.9% |
| 2014 | $2.2B | +26.8% |
| 2013 | $1.7B | +0.2% |
| 2012 | $1.7B | +20.6% |
| 2011 | $1.4B | +14.2% |
| 2010 | $1.3B | −14.2% |
| 2009 | $1.5B | +26.3% |
| 2008 | $1.2B | −11.6% |
| 2007 | $1.3B | — |